Moderna Following the early release of clinical data, Hyperliquid MRNA contract trading volume surpassed USD、OI and fell back

Article

Moderna On-chain trading volume surpassed, while open interest surged nearly 3 times before quickly falling back

BlockBeats reported that October 23，Moderna（MRNA) Early release of clinical data for a cancer vaccine triggered sharp stock-price volatility, while trading in the perpetual contract on Hyperliquid also surged.MRNA According to TradingBeats monitoring, as of today Beijing time 00: 30 the data release around MRNA contract subsequently 3 hours recorded cumulative trading of approximately 362000 contracts, 3 hours earlier, representing 9.1 times that level. The rolling 24-hour trading-volume peak briefly exceeded 104000000 USD; as of press time, 24-hour trading volume was approximately 94700000 USD, and the contract was quoted at 203.33 USD Before the information was released,MRNA notional open interest was approximately 6840000 USD, then around 2 it briefly climbed to 20310000 USD, an increase of approximately 197%; the number of open contracts simultaneously rose from 30500 contracts to 108800 contracts.

This expansion in positions did not persist. As of press time,MRNA notional OI had fallen back to approximately 6270000 USD, and the number of open contracts had declined to 30900 contracts, nearly returning to the level before the information was released.

In whale trading, one account established 6310.91 contracts of MRNA short positions during the decline, currently worth approximately 1283000 USD, making it the largest identified short position to date. Its average entry price was 188.304 USD; however, as the contract price rebounded from its low, the position is currently showing an unrealized loss of approximately 95000 USD.

Original link https://m.theblockbeats.info/flash/373318

Key points

BlockBeats said that October 23 Moderna the early release of clinical data for a cancer vaccine triggered sharp stock-price volatility.
On Hyperliquid,MRNA trading in the perpetual contract surged simultaneously.
After the data was released, 3 hours recorded cumulative trading of approximately 362000 contracts, representing 3 hours earlier, 9.1 times that level.
The rolling 24-hour trading-volume peak briefly exceeded 104000000 USD; as of press time, approximately 94700000 USD and the contract was quoted at 203.33 USD。
Notional open interest rose from approximately 6840000 USD to approximately 20310000 USD, an increase of approximately 197%, before falling back to approximately 6270000 USD。
The number of open contracts rose from 30500 contracts to 108800 contracts, then fell to 30900 contracts.
One account established 6310.91 contracts of MRNA short positions, currently worth approximately 1283000 USD, with an average entry price of 188.304 USD and an unrealized loss of approximately 95000 USD。

AI-assisted interpretation

The following is analysis, separate from reported facts. Verify important claims independently.

Trading volume represents the scale of trading over a given period; open interest represents the scale of contracts that have not yet been closed. This report shows that both expanded rapidly after the information was released, then approached their pre-release levels.

Why it matters to readers

This indicates that the contract market experienced significant but short-lived changes in trading activity and positions after the information was released.

Beginners should note that rapid changes in trading volume and open interest generally indicate increased market activity, but do not mean that the price direction has been established.

Risks and unknowns

Evidence not provided Moderna the original source or specific content of the clinical data for the cancer vaccine.
The trading, open-interest, and whale-position data in the report came from BlockBeats' account and TradingBeats monitoring and were not independently verified in the evidence.
The evidence does not identify the account holding the short position or state whether the related position subsequently changed.

Moderna Following the early release of clinical data, Hyperliquid MRNA contract trading volume surpassed USD、OI and fell back

Article

AI-assisted interpretation

Why it matters to readers

Risks and unknowns

Related Developments

Related concepts

Keep following

Security Center